advanced cholangiocarcinoma: fgfr2 inhibitors vs chemo
Published 4 years ago • 148 plays • Length 1:34Download video MP4
Download video MP3
Similar videos
-
4:12
fgfr2 inhibitors in advanced cholangiocarcinoma
-
1:00:01
webinar: targeting the fgfr pathway: infigratinib in cholangiocarcinoma
-
1:14:36
webinar: targeted treatment strategies for advanced cholangiocarcinoma -results of promising trials
-
2:31
efficacy of second-line chemotherapy in advanced cca with fgfr2 fusions
-
7:31
fgfr inhibition in advanced cca
-
3:50
fgfr-specific tkis versus multikinase inhibitors
-
5:16
the future of fgfr inhibitor treatment
-
33:05
treatment of intrahepatic cholangiocarcinoma: a disease on the rise
-
1:27:19
embracing the era of individualized therapy in advanced biliary cancers
-
2:12
dr harding on the rationale for targeting fgfr2 in cholangiocarcinoma and biliary tract cancer
-
4:03
fgfr inhibitors for cca & bladder cancer
-
2:40
the rapid growth of fgfr2 inhibitors: pemigatinib in fight-202
-
12:37
ac21 - ardaman shergill: mapk pathway targeting in cholangiocarcinoma
-
6:00
fgfr inhibitor toxicity profile
-
4:35
case 4: side effects of fgfr2 inhibitors in hcc
-
1:51
fgfr inhibitors
-
2:11
promising future for cholangiocarcinoma diagnosis and treatment
-
1:00
🚨 #futibatinib is now approved by the #fda for the treatment of #cholangiocarcinoma. #cancer
-
24:46
what is new in bile duct cancer in the last 12 months?